Is THC legal in Slovenia?

Formal status

At EU level the general reference figure for hemp is 0.3% THC, set by Regulation (EU) 2021/2115 for the crop rather than for finished products. Regulation (EU) 2023/915 sets maximum levels for hemp seed foods - 3.0 mg/kg for seeds and 7.5 mg/kg for hemp seed oil - but those categories cover seed-derived foods and do not reach a cannabinoid extract.

Slovenia raised its own cultivation threshold from 0.2% to 0.3% with effect from 3 June 2023, aligning with the EU crop figure. That rule sits in the decree on conditions for obtaining a licence to grow hemp and poppy. It is an agricultural licensing threshold for a growing crop, and it creates no allowance for a finished product.

There is no Slovenian national limit for THC in a finished food at all. What applies instead is the drugs schedule, and it is categorical. Tetrahydrocannabinol is listed in Group II in its own right, and entry 112 separately covers cannabis and its extracts with no THC threshold and no quantitative carve-out. The Supreme Court has confirmed that the prohibition applies regardless of the form and quantity in which a product is placed on the market, citing criminal judgments holding that any listed cannabis is a prohibited drug regardless of its THC content.

That absence of any numeric limb is the point: there is no level of THC at which a cannabis extract falls outside the Slovenian schedule.

Do we sell here?

No.

Our formula contains only the trace THC naturally present in a full-spectrum hemp extract, and every batch is third-party tested and published. In most of Europe that is the end of the question, because most countries set a threshold and we sit well below it.

Slovenia is different, and this is the clearest example in Europe of why a low number does not always settle the matter. Slovenia sets no THC limit for finished products at all. Its drug schedule lists cannabis extracts as such, with no threshold and no exception, and its Supreme Court has confirmed the prohibition applies regardless of the form and quantity sold. There is no level of THC at which a cannabis extract falls outside that list.

The 0.3% figure sometimes quoted for Slovenia is a farming rule about which hemp varieties may be grown. It has nothing to say about an imported supplement.

See our CBD page for Slovenia for the fuller picture.

Outlook

The 2023 alignment of the cultivation threshold with the EU figure was a small liberalisation and there is no sign of it reversing. But it operates on the farm, not on the product, so it does not affect our position.

What would matter is the absence of any finished-product rule. Slovenia has never set one, which is why the June 2026 recall of a Slovenian CBD oil over its THC content had to be framed as a general health risk rather than as a breach of a numeric limit. If Slovenia ever did set a finished-product threshold, it would for the first time create a level at which a hemp extract was lawful - which would be a significant change in a country whose current schedule has no such level.

The more likely near-term development is the one described on our CBD page: a clarification of whether the extract entry reaches low-THC products at all.

Timeline

May 2012

Vrhovno sodišče RS, Sklep X Ips 17/2012: "Navedene določbe dajejo jasen odgovor, da je promet s substanco, ki je opredeljena v seznamu iz Uredbe, prepovedan ne glede na obliko in količino, v kateri je dana v promet, razen v zakonsko določenih primerih." The judgment's own footnote cites I Ips 157/2008 and I Ips 158/2008 (27 November 2008) and I Ips 138/2006 (28 June 2007) for the proposition that any cannabis listed in the decree is a prohibited drug regardless of THC content. Note: the decision is a sklep rejecting revision as inadmissible, and was decided when cannabis sat in Skupina I.

Vrhovno sodišče RS, ECLI:SI:VSRS:2012:X.IPS.17.2012

November 2019

Uredba o razvrstitvi prepovedanih drog (Ur. l. RS 69/19), adopted 21 November 2019, published 22 November 2019 and in force 7 December 2019, places cannabis in Skupina II at entry 112: "KONOPLJA — Cannabis sativa L. — ekstrakti / rastlina / smola". The entry carries no THC threshold and no quantitative carve-out. Made under ZPPPD, whose article 7(2) permits Group II trade only for medical, veterinary, teaching and scientific-research purposes and whose article 10(1) requires ministerial authorisation. Amended through Ur. l. RS 157/20, 162/21, 8/23, 113/23, 50/25 and 92/25 without change to entry 112 beyond a footnote cross-referring to ZKMZN.

Uradni list RS št. 69/2019

February 2020

Višje sodišče v Mariboru, Sodba II Kp 5584/2016, in a cross-border online drug-sales case: "iz katere države in v katero državo je bila droga dostavljena, pa ni odločilna, saj je prodaja prepovedane droge izvršena že s sporazumom med kupcem in prodajalcem glede količine in cene in se za izvršitev zakonskih znakov kaznivega dejanja tudi ne zahteva, da je bilo blago izročeno kupcu", applying the territoriality principle and the ubiquity theory in KZ-1 article 19. On this reasoning a foreign seller's exposure crystallises when the order is accepted, not when the parcel is dispatched.

Višje sodišče v Mariboru, ECLI:SI:VSMB:2020:II.KP.5584.2016

November 2020

The Court of Justice of the European Union gives judgment in C-663/18 (Kanavape), holding that a Member State may not prohibit the marketing of CBD lawfully produced in another Member State where it is extracted from the Cannabis sativa plant in its entirety. Slovenia's Health Inspectorate records the judgment in its 2020 annual report as a "prelomna sodba", and its 2019 CBD inspection campaign does not resume in any subsequent reporting year.

Court of Justice of the European Union, C-663/18

August 2025

Zakon o konoplji za medicinske in znanstvene namene (ZKMZN, Ur. l. RS 60/25), published 5 August 2025 and in force 20 August 2025. Article 2(6) defines cannabis for medical purposes to include "ekstrakte iz konoplje… ne glede na vsebnost tetrahidrokanabinola (THC), kot tudi… ostali kanabinoidi naravnega izvora". Article 3(1) excludes the plant and its parts grown from catalogue varieties for food and industrial purposes, but not extracts. Article 2(16) redefines import to expressly include inbound movement "iz držav članic Evropske unije", abandoning ZPPPD's customs-territory anchor. It repeals and amends nothing in ZPPPD.

Uradni list RS št. 60/2025

June 2026

ZIRS orders a recall of "CBD kapljice, 1000 mg, 10 %" (Agrosloven z.o.o., Golnik; distributed by Be Healthy d.o.o., Šenčur), triggered by a RASFF notification, on the ground that "prisotnost THC (292,5 mg/kg) v zadevnem prehranskem dopolnilu, lahko predstavlja tveganje za zdravje ljudi". Both producer and distributor are Slovenian-established. The objection was the THC content, not the CBD or the product's novel-food status — and a Slovenian producer had been openly selling a 10% CBD oral supplement until this point.

Zdravstveni inšpektorat RS — Nevarni in neskladni izdelki